NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 17, 2025
- Amount
- $350,000
- Closes
- Nov 13, 2026 (in 75 days)
Similar opportunities open now
- NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)Same funderOpenNational Institutes of HealthCloses in 75 daysUp to $1.1M
- NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)Same funderOpenNational Institutes of HealthCloses in 75 days
- Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Jun 2027
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Jan 2027
- Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)Same funderOpenNational Institutes of HealthCloses in 79 days
Classification and identifiers
- Solicitation number
- PAR-25-269
- Assistance listing (CFDA)
- 93.213
Amount
$350,000
Who can apply
Small businesses and Local government agencies can all apply here. Check the eligibility details below to see if your organization fits.
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
About this opportunity
This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, probiotics, and products marketed as dietary supplements), which have a strong scientific premise to justify further clinical testing. For this NOFO, natural products include promising nutritional regimens that standardize the amount of a specific naturally occurring nutritional compound (e.g., omega-3 fatty acids, anthocyanidins, or polyphenols) and have compelling preliminary evidence. Under this NOFO, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support decisions about further development or testing of the natural product. This NOFO will prov...